Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
IUBMB Life|November 17, 2004
Polo-like kinases and Chk2 at the interface of DNA damage checkpoint pathways and mitotic regulationLyuben Tsvetkov
Cell Cycle (Georgetown, Tex.)|December 22, 2004
Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damageLyuben Tsvetkov, David F Stern
The Journal of Biological Chemistry|January 18, 2005
Interaction of chromatin-associated Plk1 and Mcm7Lyuben Tsvetkov, David F Stern
Expert Opinion on Drug Discovery|July 25, 2012
The ubiquitin-proteasome system and assays to determine responses to inhibitorsLyuben Tsvetkov, Meera Nanjundan, Maria Domino, et al.
The Journal of Biological Chemistry|December 21, 2002
Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbodyLyuben Tsvetkov, Xingzhi Xu, Jia Li, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Centrosomal Chk2 in DNA damage responses and cell cycle progressionAmnon Golan, Elah Pick, Lyuben Tsvetkov, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interactionRajinder Singh, Arvinder Sran, David C Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4Li Liu, Patrick A Mayes, Stephen Eastman, et al.
Plos One|November 3, 2018
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironmentsJong W Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, et al.
Molecular Cancer Therapeutics|July 13, 2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In VivoRocio Montes de Oca, Alireza S Alavi, Nick Vitali, et al.
Pageof 1